Correlation between symptoms and survival in patients with renal cell carcinoma;Correlación de los síntomas de los pacientes con cáncer de células renales con la supervivencia

Archivos Espanoles de Urologia

Volumn 62, Issue 3, 2009, Pages 201-206

  Valdés, Yolanda Ares ^a  

^a Hospital Universitario Comandante Manuel Fajardo   (Cuba)

Author keywords

Asymptomatic; Paraneoplastic syndrome; Renal cell carcinoma; Survival

Indexed keywords

AGED; ARTICLE; FEMALE; HUMAN; KIDNEY CARCINOMA; KIDNEY TUMOR; LONGITUDINAL STUDY; MALE; MIDDLE AGED; MORTALITY; RETROSPECTIVE STUDY;

AGED; CARCINOMA, RENAL CELL; FEMALE; HUMANS; KIDNEY NEOPLASMS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 67849122461     PISSN: 00040614     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Ares VY, Campo AR. Factores pronósticos de la supervivencia en los pacientes intervenidos por cáncer de células renales. Arch Cir Gen Dig, Disponible en: http://www.cirugest.com/revis- ta/2007/07/2007-05-07. htm, 2007
2. Volpe A, Jewett MA. The natural history of small renal masses. Nat Clin Pract Urol 2005;2(8):384.
3. Ares VY, Fragas VR. Carcinoma de células renales Incidental. Arch Esp Urol 2005; 58:417.
4. Luciani LG, Cestari R, Tallarigo C. Incidental renal cell carcinoma-age and stage characterization and clinical implications: study of 1,092 patients (1982-1997). Urol, 2000; 56: 58.
5. Jacobsohn KM, Wood CG. Adjuvant therapy for renal cell carcinoma. Semin Oncol 2006; 33: 576.
6. Gold PJ, Fefier A, Thompson TA. Paraneoplastic manifestations of renal cell carcinoma. Semin Urol Oncol, 1996; 4: 216.
7. Flocks RH, Kadesky MC. Malignant neoplasms of the kidney: An analysis of 353 patients followed five years or more. J Urol, 1958; 79: 196.
8. Mickisch GH, Mattes RH. Combination of surgery and immunotherapy in metastatic renal cell carcinoma. World J Urol , 2005; 23: 191.
9. Malaeb BS, Martin DJ, Littooy FN, el al. The utility of screening renal carcinoma in an elderly asymptomatic population. BJU Int, 2005; 95: 977.
10. Jayson M, Sanders H. Increased incidence of se- rendipitously discovered renal cell carcinoma. Urol, 1998; 51: 203.
11. Motzer RJ, Barder RH, Nancis DM. Renal cell carcinoma. N Engl J Med, 1996; 335: 865.
12. Laski ME, Vugrin D. Paraneoplastic syndromes in hypenephroma. Semin Nephro, 1989; 7: 123.
13. Bell ET. A classification of renal tumours with observation on the frequency of various types. J Urol 1938; 39: 238.
14. Leibovich BC, Pantuck AJ, Bui MHT, et al. Current staging of renal cell carcinoma. Urol Clin N Am 2003; 30: 481.
15. Patard JL, Shvarts O, Lam JS, et al. Safecty and efficacy of partial nephrectomy for all T1 tumors based an international multicenter experience. J Urol 2004; 171: 2181.
16. Robert J, Motzer, Thormas E, et al. Sunitinib versus interferon alfa in metastatic renal-cell carcinoma. N Engl J Med, 2007; 356: 115.